Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Nexgel Inc

Healthcare US NXGL

0.9518USD
-0.1782(15.77%)

Last update at 2026-03-10T20:28:00Z

Day Range

0.701.09
LowHigh

52 Week Range

1.463.14
LowHigh

Fundamentals

  • Previous Close 1.13
  • Market Cap13.08M
  • Volume6982678
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.25100M
  • Revenue TTM4.09M
  • Revenue Per Share TTM0.72
  • Gross Profit TTM 0.26M
  • Diluted EPS TTM-0.49

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.74600M -4.31000M -2.26400M -1.92300M -1.88800M
Minority interest - - - - -
Net income -6.14400M -6.30800M -2.28200M -1.92300M -1.88800M
Selling general administrative 2.38M 2.54M 1.97M 1.79M 2.40M
Selling and marketing expenses 0.44M - - - -
Gross profit 0.26M 0.00900M -0.29100M -0.13700M 0.51M
Reconciled depreciation 0.30M 0.11M 0.05M 0.07M 0.32M
Ebit -3.34800M -2.57000M -2.26000M -1.92400M -1.88800M
Ebitda -3.04400M -2.45700M -2.20200M -1.85700M -1.56600M
Depreciation and amortization 0.30M 0.11M 0.06M 0.07M 0.32M
Non operating income net other - - - - -
Operating income -3.34800M -2.57000M -2.26000M -1.92400M -1.88800M
Other operating expenses 5.40M 4.12M 2.93M 2.64M 4.10M
Interest expense 1.34M 2.00M 0.01000M 0.00000M 0.00000M
Tax provision - - - - 0.00000M
Interest income - - - - -
Net interest income -1.33600M -1.99800M -0.01000M 0.00000M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.40M 2.00M 0.02M -0.00100M -
Total revenue 2.05M 1.55M 0.67M 0.72M 2.21M
Total operating expenses 3.60M 2.58M 1.97M 1.79M 2.40M
Cost of revenue 1.79M 1.54M 0.96M 0.85M 1.70M
Total other income expense net -1.39800M -1.74000M -0.00400M 0.00100M -
Discontinued operations - - - - -
Net income from continuing ops -4.74600M -4.31000M -2.26400M -1.92300M -1.88800M
Net income applicable to common shares -4.74600M -4.31000M -2.26400M -1.92300M -1.88800M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 9.96M 10.36M 16.98M 2.26M 1.89M
Intangible assets 0.33M 0.02M 0.03M 0.05M -
Earning assets - - - - -
Other current assets 0.40M 0.17M 0.08M 0.03M 0.04M
Total liab 4.79M 2.72M 4.90M 2.19M 1.51M
Total stockholder equity 4.70M 7.64M 12.09M 0.07M 0.38M
Deferred long term liab - - - - -
Other current liab 0.74M 0.37M 0.33M 0.21M 0.07M
Common stock 0.00600M 0.00600M 0.00600M 0.10M 0.06M
Capital stock 0.00600M 0.00600M 0.00600M 0.10M 0.06M
Retained earnings -14.71500M -11.55800M -6.81200M -2.50200M -0.23800M
Other liab - - - - -
Good will 1.13M 0.31M 0.31M 0.31M 0.00000M
Other assets - 0.06M 0.06M 0.18M 0.18M
Cash 2.70M 1.10M 13.35M 0.03M 0.26M
Cash and equivalents - - - - -
Total current liabilities 2.55M 0.86M 2.89M 1.33M 0.80M
Current deferred revenue 0.02M - 0.05M 0.04M 0.01M
Net debt 0.10M 0.98M -9.08600M 1.25M 0.66M
Short term debt 0.56M 0.22M 2.25M 0.42M 0.21M
Short long term debt 0.33M 0.01M 2.05M 0.22M -
Short long term debt total 2.80M 2.08M 4.26M 1.28M 0.92M
Other stockholder equity 19.41M 19.19M 18.89M 2.47M 0.56M
Property plant equipment - 2.46M 2.65M 1.36M 1.20M
Total current assets 5.05M 7.50M 13.93M 0.36M 0.51M
Long term investments - - - - -
Net tangible assets - 7.31M 11.74M -0.28700M 0.38M
Short term investments 0.00000M 5.51M - - -
Net receivables 0.63M 0.22M 0.21M 0.07M 0.10M
Long term debt 0.51M 0.27M 0.27M 0.26M -
Inventory 1.32M 0.50M 0.29M 0.23M 0.11M
Accounts payable 1.23M 0.27M 0.25M 0.66M 0.51M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.10M 0.06M 0.06M 0.18M 0.18M
Deferred long term asset charges - - - - -
Non current assets total 4.90M 2.85M 3.06M 1.89M 1.38M
Capital lease obligations 1.96M 1.80M 1.95M 0.81M 0.92M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -5.59500M -0.26900M -0.31200M -5.49900M 0.00000M
Change to liabilities 0.01M -0.44300M 0.17M 0.20M 0.09M
Total cashflows from investing activities -5.59500M -0.26900M -0.31200M -0.31200M -0.31200M
Net borrowings -3.66200M 2.98M 0.51M 0.51M 0.51M
Total cash from financing activities -3.66200M 16.34M 1.88M 2.08M 1.54M
Change to operating activities -0.02100M 0.04M 0.07M -0.08400M -0.12100M
Net income -4.74600M -4.31000M -2.26400M -1.92300M -1.88800M
Change in cash -12.24900M 13.32M -0.22900M 0.26M 1.54M
Begin period cash flow 13.35M 0.03M 0.26M 0.00000M 0.00000M
End period cash flow 1.10M 13.35M 0.03M 0.26M 0.00000M
Total cash from operating activities -2.99200M -2.75300M -1.80100M -1.81400M -1.54400M
Issuance of capital stock 0.00000M 13.47M 1.37M 0.73M -
Depreciation 0.30M 0.11M 0.05M 0.07M 0.32M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.21100M -0.05800M -0.09900M -0.01200M -0.00300M
Change to account receivables -0.01300M -0.13700M 0.03M -0.06800M 0.07M
Sale purchase of stock - - - - -
Other cashflows from financing activities -5.59500M 2.98M 0.51M 1.34M 1.54M
Change to netincome 0.55M 0.10M 0.23M 0.00300M -0.01400M
Capital expenditures 0.10M 0.27M 0.31M 0.31M 0.31M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.23400M -0.59300M 0.18M 0.04M 0.04M
Stock based compensation 0.30M 0.28M 0.23M 0.00400M -
Other non cash items 1.39M 1.98M 0.00200M -0.00100M -0.01400M
Free cash flow -3.08800M -3.02200M -2.11300M -1.81400M -1.54400M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NXGL
Nexgel Inc		 -0.1782 15.77% 0.95 - - 3.32 2.89 3.87 -5.9093
ISRG
Intuitive Surgical Inc		 -7.71 1.56% 485.85 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA		 -0.25 0.20% 122.50 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme		 4.90 2.00% 249.71 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 -1.58 0.95% 163.88 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

View All

Profile

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Nexgel Inc

2150 Cabot Boulevard West, Langhorne, PA, United States, 19047

Key Executives

Name Title Year Born
Mr. Adam R. Levy CEO, Pres & Director 1963
Mr. Adam E. Drapczuk III Chief Financial Officer 1976
Mr. David Stefansky Exec. Director 1971
Mr. Gregory Robb VP of Operations NA
Mr. Adam R. Levy CEO, President & Director 1963
Mr. Gregory Robb Vice President of Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.